Potentiation of isoniazid-induced liver toxicity by rifampicin in a combinational therapy of antitubercular drugs (rifampicin, isoniazid and pyrazinamide) in Wistar rats: A toxicity profile study

Hepatology Research

Volumn 37, Issue 10, 2007, Pages 845-853

  Tasduq, Sheikh Abdullah ^a   Kaiser, Peerzada ^a   Sharma, Subhash Chander ^a   Johri, Rakesh Kamal ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Antitubercular drugs; Isoniazid; Liver toxicity; Pyrazinamide; Rat; Rifampicin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; CATALASE; CYTOCHROME P450 2E1; GLUTATHIONE; GLUTATHIONE PEROXIDASE; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL CULTURE; CELL DAMAGE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME ASSAY; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERURICEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID PEROXIDATION; LIVER CELL; LIVER TOXICITY; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; TOXICITY TESTING; WISTAR RAT;

EID: 34548161720     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2007.00129.x     Document Type: Article

References (21)

1. Santhosh S, Sini TK, Anandan R, Mathew PT. Effect of chitosan supplementation on antitubercular drugs-induced hepatotoxicity in rats. Toxicology 2006; 219: 53-9.
2. Wong WM, Wu PC, Yuen MF, Cheng CC, Yew WW. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology 2000; 31: 201-6.
3. Stout JE, Engemann JJ, Cheng AC, Fortenberry ER, Hamilton CD. Rifampin and pyrazinamide for treatment of latent tuberculosis infection: Is it safe? Am J Respir Crit Care Med 2003; 167: 809-10.
4. Alexender MR, Louie SG, Guernsey BG. Isoniazid associated hepatitis. Clin Pharmacol 1982; 1: 148-53.
5. Tasduq SA, Peerzada K, Koul S, Bhat R, Johri RK. Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin. Hepatol Res 2005; 31: 132-5.
6. Tasduq SA, Kaisar P, Gupta DK et al. Protective effect of a 50% hydroalcoholic fruit extract of Emblica officinalis against anti-tuberculosis drugs induced liver toxicity. Phytother Res 2005; 19: 193-7.
7. Abhijit C, Amal S, Koutilya B, Subhadip G, Dhira RS, Gopal KD. Mitochondrial oxidative stress and permeability transition in Isoniazid and Rifampicin induced liver injury in mice. J Hepatol 2006; 45: 117-26.
8. Tasduq SA, Singh K, Satti NK, Gupta DK, Suri KA, Johri RK. Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination. Human Exp Toxicol 2006; 25: 111-18.
9. Alia M, Ramos S, Mateos R, Granado-Serrano AB, Bravo L, Luis G. Quercetin protects human hepatoma HepG2 against oxidative stress induced by tert -butyl hydroperoxide. Toxicol Appl Pharmacol 2006; 212: 110-18.
10. Tasaduq SA, Singh K, Sethi S et al. Hepatocurative and anti-oxidant profile of HP-1, a poly herbal phytomedicine. Human Exp Toxicol 2003; 22: 639-45.
11. John Dunn. Assessment of liver damage and dysfunction. Practice 1992; 14: 193-200.
12. Uchida K, Shiraishi M, Naito Y, Torii Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 1999; 274: 2234-42.
13. Zhuge J, Cederbaum AI. Increased toxicity by transforming growth factor-beta 1 in liver cells overexpressing CYP2E1. Free Radic Biol Med 2006; 41: 1100-12.
14. Reed DJ. Glutathione: Toxicological implications. Annu Rev Pharmacol Toxicol 1990; 30: 603-31.
15. Sarich TC, Adams SP, Petricca G, Wright JM. Inhibition of Isoniazid-Induced Hepatotoxicity in Rabbits by Pretreatment with an Amidase Inhibitor. J Pharmacol Exp Ther 1999; 289: 695-702.
16. Pessayre D, Bentata M, Degott C, Nouel O, Miguet JP, Rueff B. Isoniazid -rifampicin fulminant hepatitis. A possible consequence of the enhancement of isoniazid hepatotoxicity by enzyme induction. Gastroenterology 1997; 72: 284-9.
17. Koop DR, Chemosky A, Brass EP. Identification and induction of cytochrome P450 2E1 in rat Kupffer cells. J Pharmacol Exp Ther 1991; 258: 1072-6.
18. Jeong HG. Inhibition of cytochrome P450 2E1 expression by oleanolic acid: Hepatoprotective effects against carbon tetrachloride-induced hepatic injury. Toxicol Lett 1999; 105: 215-22.
19. Wang PY, Kaneko T, Wang Y, Sato A. Acarbose alone or in combination with ethanol potentiates the hepatotoxicity of carbon tetrachloride and acetaminophen in rats. Hepatology 1999; 29: 161-5.
20. Dai Y, Cederbaum AI. Cytotoxicity of acetaminophen in human cytochrome P4502E1-transfected HepG2 cells. J Pharmacol Exp Ther 1995; 273: 1497-505.
21. Caro AA, Cedarbaum AI. Role of phospholipase A2 activation and calcium in CYP2E1-dependent toxicity in HepG2 cells. J Biol Chem 2003; 278: 33866-77.